Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alejandra Dávila-Barclay has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    One Health genomic epidemiology reveals cryptic transmission and surveillance gaps in a decade-long urban rabies epidemic in Arequipa, Peru

    by Kirstyn Brunker, Alejandra Dávila-Barclay, Elvis W. Díaz, Sandeep Kasaragod, Rowan Durrant, Katie Hampson, Edith Zegarra, Ynés Monroy, Ricardo Castillo-Neyra

    Persistent local foci remain a major barrier to eliminating dog-mediated rabies, yet the processes sustaining transmission at micro-scales, particularly within complex urban systems, remain poorly understood. We apply an integrated One Health genomic epidemiology framework to reconstruct a decade-long rabies virus (RABV) epidemic in Arequipa, Peru. Combining 133 newly generated whole genomes with existing data, we assembled the most comprehensive canine RABV dataset in Latin America and used whole-genome-informed phylogenetic, phylodynamic and landscape analyses to trace the epidemic from its first detection in 2015. Transmission was dominated by a single lineage, estimated to have been introduced around 2012, which circulated for approximately three years before detection. We estimate that only 1–2% of infections are routinely detected, revealing extensive cryptic transmission and highlighting the limitations of case-based metrics for verifying disease freedom. Although additional regional and transboundary introductions were identified, only one resulted in sustained transmission. Within Arequipa city, transmission was highly structured, concentrated in densely populated and socioeconomically deprived areas, and shaped by urban connectivity. Roads and dry water channels facilitated spread, while rivers acted as partial barriers. Our findings demonstrate that rabies persistence reflects interacting processes across spatial scales, from regional introductions to highly structured urban transmission. They highlight the importance of genomic-informed, spatially targeted surveillance and control strategies to identify and address persistent transmission foci and accelerate progress towards elimination. Funding: US National Institute of Allergy and Infectious Diseases, US Fogarty International Center, Wellcome Trust, UK Medical Research Council, and UK Engineering and Physical Sciences Research Council.


  • Open Access

    Genome-confirmed Pluralibacter gergoviae urinary tract infection in a companion animal in Peru

    by Joel Palomino-Farfán, Alejandra Dávila-Barclay, Luis Alvarez, Juan Siuce, Diego Cuicapuza, Alejandra Castro, Pablo Tsukayama, Guillermo Salvatierra

  • Open Access

    Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024

    by Benjamin Sobkowiak, Amy Langdon, Pedro E. Romero, Gabriel Carrasco-Escobar, Diego Villa, Renato Cava Miller, Víctor Cornejo Villanueva, Alejandra Dávila-Barclay, Diego Cuicapuza, Guillermo Salvatierra, et al.

    Background: Peru recorded one of the world’s highest COVID-19 mortality rates, with nearly 4.5 million reported cases and 220,000 deaths by March 2024. Understanding the emergence and spread of SARS-CoV-2 variants in this context is key to informing effective public health responses. This study describes the genomic diversity, transmission dynamics, and geographic spread of SARS-CoV-2 in Peru from 2020 to 2024. Methods: We analyzed nearly 50,000 high-quality public SARS-CoV-2 genome sequences collected nationwide between March 2020 and March 2024. Phylogeographic and mutational analyses were performed to identify variant lineages, trace their origins, and map viral movements within and beyond Peru. Results: We show that Peru’s epidemic waves were shaped by the emergence of locally evolved variants, including Lambda (C.37), Gamma (P.1.12), and Omicron (XBB.2.6 and DJ.1) sub-lineages. The city of Lima acted as the primary hub for inter-regional spread, accounting for 47.3% of inferred viral movements to other departments, notably Ancash, Cusco, and Piura. Peru was the source of various lineages that spread internationally, primarily to Chile, the USA, and Europe. Mutational analysis highlighted critical mutations in the spike protein, including L452Q and F490S in Lambda, associated with immune evasion and increased transmissibility. Conclusions: This work demonstrates the capacity of genomic surveillance in Peru to detect and track emerging SARS-CoV-2 variants, providing insights into regional and global transmission dynamics in a high-transmission, middle-income country setting. Sustained, cost-effective genomic monitoring, combined with strengthened bioinformatics and laboratory capacity, is essential for pandemic preparedness in resource-limited settings.


  • Open Access

    Genomic surveillance of multidrug-resistant Escherichia coli and Klebsiella in clinical and wastewater isolates from a paediatric hospital in Lima, Peru

    by Brenda Ayzanoa, Camila Castillo-Vilcahuaman, Guillermo Salvatierra, Alejandra Dávila-Barclay, Diego Cuicapuza, Janet Huancachoque, Maritza Calderón, Emiliana Rizo-Patrón, Carlos Santillán-Salas, Robert H. Gilman, et al.

    The environmental spread of antibiotic-resistant bacteria is a growing global health concern, particularly in low- and middle-income countries where limited wastewater treatment infrastructure may facilitate the dissemination of multidrug-resistant (MDR) organisms. Escherichia coli and Klebsiella spp. are clinically significant MDR pathogens commonly associated with healthcare-associated infections and known to carry diverse antimicrobial resistance genes (ARGs). In this study, we conducted genomic and phenotypic analyses of E. coli and Klebsiella spp. isolated from hospital wastewater and paediatric patient samples at a tertiary hospital in Lima, Peru, between 2017 and 2019. A total of 157 isolates were collected ( E. coli , n =113; Klebsiella spp., n =44). Whole-genome sequencing was performed to identify ARGs and assess sequence types (STs). MDR phenotypes were more prevalent among wastewater isolates (73.5%) compared to clinical isolates (56.8%, P =0.014), while extended-spectrum β -lactamase production was more frequent in clinical isolates (52.9 % vs. 13.9 %, P E. coli isolates from urine. Genomic analysis revealed greater sequence type diversity among wastewater isolates, including high-risk STs such as ST10, ST131 and ST405. The Shannon diversity index was higher for wastewater-derived isolates (H=3.45) compared to clinical isolates (H=2.95), indicating a more heterogeneous resistance reservoir. In total, 1,302 resistance gene hits were identified, with clinical isolates carrying significantly more ARGs per genome than wastewater isolates. A small number of shared STs were detected in both sources, suggesting possible overlap in bacterial populations. Our findings highlight the potential role of hospital wastewater as a reservoir of antimicrobial resistance and support the value of integrating environmental and clinical genomic surveillance. Wastewater-based monitoring may inform infection control efforts and guide interventions to curb the spread of AMR within healthcare settings and their surrounding environments.


  • Open Access

    Timeliness in canine rabies outbreak report and response

    by Elvis W. Díaz, Alejandra Dávila-Barclay, Antuannete Vela, Laura D. Tamayo, Valerie A. Paz-Soldan, Claudia Mena, Ricardo Castillo-Neyra

    Introduction Timely response to zoonotic disease outbreaks is crucial to minimizing their impact on the health and wellbeing of people and animals. Monitoring and improving the speed of response, using established outbreak milestones and timeliness metrics, is key to preventing further spread. Despite training and a decade of expertise in case response, persistent delays in these processes continue to hinder effective outbreak responses. Dog- mediated rabies, a classic One Health challenge, remains a significant public health concern in many parts of the world. In Arequipa, Peru, rabies has re-emerged and caused recurrent outbreaks over the past decade, despite substantial control efforts. Addressing the drivers of these delays is vital for improving rabies control. In this study, we use dog rabies as a model to examine delays in zoonotic outbreak response, as well as potential solutions, applying and adapting the Outbreak Milestones and Timeliness Metrics framework. We calculated the timeliness of rabies surveillance and response activities in Arequipa from 2015 to 2024 and identified key barriers contributing to delays. Methods Using canine rabies outbreak response reports from 2015 to 2024 in Arequipa, Peru, we classified One Health outbreak milestones pertaining to the report and response system and calculated timeliness metrics between key processes. Kruskal-Wallis and Dunn tests were applied to measure delays by process, year, and micro-health network. Qualitative analysis of narrative field reports identified underlying causes of delays. Results The longest delay occurred between the detection of behavior change in dogs and initial reporting, averaging 2.52 days (SD = 2.28), while the shortest delay was between diagnosis and outbreak control, averaging 0.76 days (SD = 0.92). Intermediate delays were observed between report and sample shipment and diagnosis and control with averages of 1.28 days (SD = 1.30) and 1.09 days (SD = 1.38), respectively. Delay-related barriers included dog owners’ lack of awareness and reluctance to report symptoms, logistical challenges in sample collection, and delays in implementing outbreak control measures. Additional barriers included confusion about reporting procedures and reluctance from dog owners to share information about their dogs which hindered timely response. Conclusions Delays in rabies reporting and response in Arequipa are primarily driven by slow reporting following behavior changes in dogs and logistical problems with sample collection and control and containment measures. Although diagnosis and outbreak responses are comparatively more efficient, inconsistencies remain. Strengthening community awareness and engagement for reporting, improving intersectoral coordination between health authorities, and optimizing logistics are critical to reducing delays and improving outbreak control.

  • Open Access

    Open letter: challenging the removal of key bacteria from the updated 2024 WHO Bacterial Priority Pathogen List

    by Dessislava Veltcheva, Julia Moreno-Manjón, Alejandra Dávila-Barclay, Birgitta Duim, Martin C.J. Maiden, Samuel K. Sheppard


  • Open Access

    Antibiotic Use and Resistance Knowledge Assessment of Personnel on Chicken Farms with High Levels of Antimicrobial Resistance: A Cross-Sectional Survey in Ica, Peru

    by María Dávalos-Almeyda, Agustín Guerrero, Germán Medina, Alejandra Dávila-Barclay, Guillermo Salvatierra, Maritza Calderón, Robert H. Gilman, Pablo Tsukayama

    Poultry farming represents Peru’s primary food animal production industry, where antimicrobial growth promoters are still commonly used, exerting selective pressure on intestinal microbial populations. Consumption and direct animal-to-human transmission have been reported, and farmworkers are at high risk of colonization with resistant bacteria. We conducted a cross-sectional survey among 54 farmworkers to understand their current antimicrobial resistance (AMR) awareness in Ica, Peru. To gain insight into the potential work-related risk of exposure to bacteria, we also measured the AMR rates in Escherichia coli isolated among 50 broiler chickens. Farmworkers were unaware of antimicrobial resistance (31.5%) or antibiotic resistance (16.7%) terms. Almost two-thirds (61%) consumed antibiotics during the previous month, and only 42.6% received a prescription from a healthcare professional. A total of 107 E. coli chicken isolates were obtained, showing a high frequency of multidrug-resistant (89.7%) and extended-spectrum beta-lactamase (ESBL) production (71.9%). Among ESBL-producer isolates, 84.4% carried the blaCTX-M gene. Results identified gaps in knowledge that reflect the need for interventions to increase antimicrobial awareness among poultry farmworkers. The high AMR rates among E. coli isolates highlight the need to reduce antimicrobial use in poultry farms. Our findings reveal a critical need for effective policy development and antimicrobial stewardship interventions in poultry production in Ica, Peru.


  • Open Access

    The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America

    by Pedro E. Romero, Alejandra Dávila-Barclay, Guillermo Salvatierra, Luis González, Diego Cuicapuza, Luis Solís, Pool Marcos-Carbajal, Janet Huancachoque, Lenin Maturrano, Pablo Tsukayama

    The evolution of SARS-CoV-2 variants with potentially increased transmissibility, virulence, and resistance to antibody neutralization poses new challenges for the control of COVID-19 (1), particularly in low- and middle-income countries (LMICs) where transmission remains high and vaccination progress is still incipient.


  • Open Access

    The Emergence of SARS-CoV-2 Variant Lambda (C.37) in South America

    by Pedro E. Romero, Alejandra Dávila-Barclay, Guillermo Salvatierra, Luis González, Diego Cuicapuza, Luis Solis, Pool Marcos-Carbajal, Janet Huancachoque, Lenin Maturrano, Pablo Tsukayama

    We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. It presents seven nonsynonymous mutations in the Spike gene (Δ247-253, G75V, T76I, L452Q, F490S, T859N) and a deletion in the ORF1a gene (Δ3675-3677) also found in variants of concern (VOCs) Alpha, Beta, and Gamma. Initially reported in Lima, Peru, in late December 2020, it now accounts for 97% of Peruvian public genomes in April 2021. It is expanding in Chile and Argentina, and there is evidence of onward transmission in Colombia, Ecuador, Mexico, the USA, Germany, and Israel. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda.


  • Open Access

    Draft Genome Sequence of a New Delhi Metallo-β-Lactamase (NDM-1)-Producing Providencia stuartii Strain Isolated in Lima, Peru

    by Lizet Lezameta, Diego Cuicapuza, Alejandra Dávila-Barclay, Susan Torres, Guillermo Salvatierra, Pablo Tsukayama, Jesús Tamariz

    Providencia stuartii is an opportunistic pathogen of the Enterobacteriales order. Here, we report the 4,594,658-bp draft genome sequence of a New Delhi metallo-β-lactamase (NDM-1)-producing Providencia stuartii strain that was isolated from an emergency patient in a private clinic in Lima, Peru.